Research Topics
Genomes and Genes
| Douglas B EvansSummaryAffiliation: The University of Texas Country: USA Publications
| Collaborators
|
Detail Information
Publications
The added value of multidisciplinary care for patients with pancreatic cancerDouglas B Evans
Ann Surg Oncol 15:2078-80. 2008
Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic headDouglas B Evans
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
J Clin Oncol 26:3496-502. 2008..We conducted a phase II trial to assess the outcomes of patients who received preoperative gemcitabine-based chemoradiation and pancreaticoduodenectomy (PD) for stage I/II pancreatic adenocarcinoma...
On "Posterior retroperitoneoscopic adrenalectomy--results of 560 procedures in 520 patients"Douglas B Evans
University of Texas, M.D. Anderson Cancer Center, Houston, TX 77030, USA
Surgery 140:951-2. 2006
Preoperative chemoradiation for pancreatic cancerDouglas B Evans
The Department of Surgical Oncology and the Pancreatic Cancer Study Group, The University of Texas M D Anderson Cancer Center, Houston, 77030 4009, USA
Semin Oncol 32:S25-9. 2005..Clinical trials involving patients with localized pancreatic cancer are needed that use accurate, reproducible pretreatment staging techniques, and standardized pathologic evaluation of surgical specimens...
Invited commentary: medullary thyroid cancer: the importance of RET testingDouglas B Evans
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
Surgery 141:96-9. 2007
Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiationJinyun Chen
Department of Epidemiology, University of Texas M D Anderson Cancer Center, Houston, 77030, USA
Ann Surg Oncol 16:431-9. 2009..13 (1.04-4.36), 3.18 (1.37-7.39), and 10.09 (3.17-32.05), respectively. These findings suggest these polymorphisms in the cell cycle genes are promising prognostic markers for patients with pancreatic cancer...
Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cellsGuido M Sclabas
Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Clin Cancer Res 11:440-9. 2005..Our results also imply that TrkB receptor may be a novel therapeutic target for pancreatic cancer...
Secreted interleukin-1alpha induces a metastatic phenotype in pancreatic cancer by sustaining a constitutive activation of nuclear factor-kappaBDavide Melisi
Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Mol Cancer Res 7:624-33. 2009..Our findings further support the possible link between inflammation and cancer and suggest that IL-1alpha may be a potential therapeutic target for treating pancreatic adenocarcinoma...
HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomasMichael J Gray
Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, 1515 Holcomb Boulevard, Houston, TX 77030, USA
Oncogene 24:3110-20. 2005..These data suggest that the binding of both STAT3 and HIF-1alpha to the VEGF promoter is required for maximum transcription of VEGF mRNA following hypoxia...
Inhibition of constitutive NF-kappa B activity by I kappa B alpha M suppresses tumorigenesisShuichi Fujioka
Department of Surgical Oncology, The University of Texas, Houston 77030, USA
Oncogene 22:1365-70. 2003..Taken together, these results suggest that the inhibition of NF-kappa B signaling can suppress tumorigenesis of pancreatic cancer cells and that the NF-kappa B signaling pathway is a potential target for anticancer agents...
Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic headGauri R Varadhachary
Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Box 426, Houston, TX 77030, USA
J Clin Oncol 26:3487-95. 2008..We conducted a phase II trial of preoperative gemcitabine and cisplatin chemotherapy in addition to chemoradiation (Gem-Cis-XRT) and pancreaticoduodenectomy (PD) for patients with stage I/II pancreatic adenocarcinoma...
NF-kappaB and AP-1 connection: mechanism of NF-kappaB-dependent regulation of AP-1 activityShuichi Fujioka
Department of Surgical Oncology, Box 107, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
Mol Cell Biol 24:7806-19. 2004..Thus, our study revealed a distinct and essential role of NF-kappaB in participating in the regulation of elk-1, c-fos, and VEGF expression...
Stabilization of p53 is a novel mechanism for proapoptotic function of NF-kappaBShuichi Fujioka
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
J Biol Chem 279:27549-59. 2004..Thus, these findings reveal a mechanism of NF-kappaB-regulated proapoptotic signaling...
Survival and quality of life of patients with resected pancreatic adenocarcinoma treated with adjuvant interferon-based chemoradiation: a phase II trialMatthew H G Katz
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, USA
Ann Surg Oncol 18:3615-22. 2011..We conducted a phase II trial to assess the survival duration and quality of life of patients who received adjuvant interferon-based chemoradiation for pancreatic adenocarcinoma after pancreaticoduodenectomy...
Long-term survival after multidisciplinary management of resected pancreatic adenocarcinomaMatthew H G Katz
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
Ann Surg Oncol 16:836-47. 2009..We evaluated long-term survival and patterns of recurrence in patients treated for PC with contemporary staging and multimodality therapy...
Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in miceTodd W Bauer
Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA
Cancer Res 65:7775-81. 2005..Our study shows the importance of the uPA/uPAR system in pancreatic carcinoma cell migration and invasion. These findings suggest that uPAR is a potential target for therapy in patients with pancreatic cancer...
Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survivalChandrajit P Raut
Department of Surgical Oncology, Unit 444, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA
Ann Surg Oncol 13:582-94. 2006..Noninvasive IPMN, even if present at the pancreatic margin, was not associated with recurrent disease. In contrast, invasive IPMN was associated with early recurrence and short survival...
Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vaterSunil Krishnan
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
Int J Radiat Oncol Biol Phys 70:735-43. 2008..We retrospectively compared treatment outcomes in patients treated with pancreaticoduodenectomy alone versus those who received additional adjuvant CRT...
Effects of base excision repair gene polymorphisms on pancreatic cancer survivalDonghui Li
Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 1402, USA
Int J Cancer 120:1748-54. 2007..These observations need to be confirmed in a larger study of homogenous patient population...
Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapyGauri R Varadhachary
Department of Gastrointestinal Medical Oncology, Unit 426, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA
Ann Surg Oncol 13:1035-46. 2006....
Concurrent capecitabine and upper abdominal radiation therapy is well toleratedPrajnan Das
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, USA
Radiat Oncol 1:41. 2006..Therefore, capecitabine and concurrent radiotherapy to the upper abdomen appears to be well tolerated. Capecitabine may serve as an alternative to bolus or infusional 5-FU during chemoradiation for upper gastrointestinal malignancies...
Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survivalDonghui Li
Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77230 1402, USA
Cancer Res 66:3323-30. 2006..These observations suggest that polymorphisms of genes involved in the repair of DNA double-strand breaks significantly affect the clinical outcome of patients with pancreatic cancer...
Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancerChristopher H Crane
Department of Radiation Oncology, Unit 97, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
J Clin Oncol 24:1145-51. 2006..To study the safety of bevacizumab with capecitabine-based chemoradiotherapy...
Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancerDonghui Li
Department of Gastrointestinal Medical Oncology, The University of Texas, M D Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 426, Houston, TX 77030, USA
Carcinogenesis 27:103-11. 2006..9, 95% CI: 1.2-6.9) and among females (AOR: 2.5, 95% CI: 1.1-5.7). These data suggest that polymorphisms of the CYP1A2 and NAT1 genes modify the risk of pancreatic cancer...
Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancerOliver Stoeltzing
Department of Cancer Biology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030 4009, USA
Am J Pathol 163:1001-11. 2003..02). Our results suggest that autocrine activation of the IGF-IR system significantly affects VEGF expression and angiogenesis in human pancreatic cancer. Thus, IGF-IR may be a valid target in the treatment of pancreatic cancer...
TrkBT1 induces liver metastasis of pancreatic cancer cells by sequestering Rho GDP dissociation inhibitor and promoting RhoA activationZhongkui Li
Departments of Surgical Oncology and Molecular and Cellular Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Cancer Res 69:7851-9. 2009..Therefore, our results showed that TrkBT1 overexpression induces liver metastasis of pancreatic cancer and uncovered a unique signaling mechanism by which TrkBT1 sequesters GDI and activates RhoA signaling...
Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapySunil Krishnan
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
Cancer 110:47-55. 2007....
Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinomaChandrajit P Raut
Department of Surgical Oncology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Ann Surg 246:52-60. 2007..To better understand the impact of a microscopically positive margin (R1) on patterns of disease recurrence and survival after pancreaticoduodenectomy (PD) for pancreatic adenocarcinoma...
Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinomaJohn J Liang
Department of Pathology, The University of Texas M D Anderson Cancer, Houston, TX 77030, USA
Clin Cancer Res 14:7043-9. 2008..MAP4K4 plays an important role in transformation, invasiveness, adhesion, and cell migration. However, the expression of MAP4K4 and its significance in pancreatic ductal adenocarcinoma (PDA) has not been studied...
Borderline resectable pancreatic cancer: the importance of this emerging stage of diseaseMatthew H G Katz
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230 1402, USA
J Am Coll Surg 206:833-46; discussion 846-8. 2008..There is no optimal treatment schema for this distinct stage of disease, so the role of surgery is undefined...
Achieving eugastrinemia in MEN1 patients: both duodenal inspection and formal lymph node dissection are importantPaxton V Dickson
Department of Surgical Oncology, University of Texas M D Anderson Cancer Center, Houston, TX 77030 4008, USA
Surgery 150:1143-52. 2011..Controversy exists regarding the role and extent of operation for patients with multiple endocrine neoplasia type 1 (MEN1) and hypergastrinemia...
Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancerDonghui Li
Department of Gastrointestinal Medical Oncology Unit 426, The University of Texas M D Anderson Cancer Center, Houston, TX 77230 1402, USA
J Clin Oncol 24:1720-8. 2006..Our goal was to determine whether single nucleotide polymorphisms (SNPs) in DNA repair genes influence the clinical outcome of pancreatic cancer...
Function of nuclear factor kappaB in pancreatic cancer metastasisShuichi Fujioka
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Clin Cancer Res 9:346-54. 2003....
Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptorsMichael J Gray
Department of Cancer Biology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 21201, USA
Cancer Res 65:3664-70. 2005..Thus, NRP-1 may play distinct growth regulatory roles in different tumor types, and altering NRP-1 expression or function may be a means of influencing the growth of pancreatic cancers...
Risk factors for pancreatic cancer: case-control studyManal M Hassan
Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Am J Gastroenterol 102:2696-707. 2007..We evaluated the independent effects of multiple risk factors for pancreatic cancer and determined whether the magnitude of cigarette smoking was modified by other risk factors in men and women...
Regulatory role of c-Met in insulin-like growth factor-I receptor-mediated migration and invasion of human pancreatic carcinoma cellsTodd W Bauer
Department of Surgical Oncology, Unit 444, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Mol Cancer Ther 5:1676-82. 2006..Elucidation of the signaling pathways that contribute to tumor progression and metastasis should provide a foundation for the development of targeted therapies for pancreatic carcinoma...
Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiationJiansheng Wang
Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Cancer 118:3801-11. 2012..However, the prognostic significance of tumor involvement of the resected vein in patients who received neoadjuvant therapy is unclear...
Pancreaticoduodenectomy with vascular resection: margin status and survival durationJennifer F Tseng
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
J Gastrointest Surg 8:935-49; discussion 949-50. 2004....
Future chemoradiation strategies in pancreatic cancerChristopher H Crane
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Semin Oncol 34:335-46. 2007..Herein, we discuss the relative merits of strategies that seek to improve outcome through these novel means and present recent data from novel strategies that will provide the background for future trials...
Recurrence of adrenal cortical carcinoma following resection: surgery alone can achieve results equal to surgery plus mitotaneElizabeth G Grubbs
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Ann Surg Oncol 17:263-70. 2010..Because of the limitations of this study, we investigated the influences of surgery and adjuvant mitotane in a large series of ACC patients evaluated and treated at a single referral center...
XRCC2 and XRCC3 gene polymorphism and risk of pancreatic cancerLi Jiao
Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Am J Gastroenterol 103:360-7. 2008..We hypothesized that the altered HR repair capacity conferred by single nucleotide polymorphisms (SNPs) would modify individual susceptibility to sporadic pancreatic cancer...
Src activation of Stat3 is an independent requirement from NF-kappaB activation for constitutive IL-8 expression in human pancreatic adenocarcinoma cellsJose G Trevino
Department of Cancer Biology, Unit 179, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Angiogenesis 9:101-10. 2006..We therefore suggest that Src activation, through phosphorylation of STAT3, and NF-kappaB are all required for expression of IL-8 a critical angiogenic-promoting factor in pancreatic adenocarcinomas...
Nuclear factor kappa B activation is a potential target for preventing pancreatic carcinoma by aspirinGuido M Sclabas
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 103:2485-90. 2005..Aspirin-mediated antiinflammatory approaches might be an effective strategy to prevent pancreatic carcinoma...
Pheochromocytoma and medullary thyroid carcinoma: a new genotype-phenotype correlation of the RET protooncogene 891 germline mutationCamilo Jimenez
The University of Texas MD Anderson Cancer Center, Department of Endocrine Neoplasia and Hormonal Disorders, 1515 Holcombe Boulevard, Unit 435, Houston, Texas 77030, USA
J Clin Endocrinol Metab 89:4142-5. 2004..These findings indicate that patients with this mutation should be screened for pheochromocytoma...
Routine pre-operative ultrasonography for papillary thyroid cancer: effects on cervical recurrenceChristy L Marshall
Department of Surgical Oncology, University of Texas, M D Anderson Cancer Center, Houston, TX 77030, USA
Surgery 146:1063-72. 2009..We report the follow-up of patients with PTC in whom pre-operative US was used to accurately stage the extent of neck disease...
Neoadjuvant therapy for resectable pancreatic cancerChandrajit P Raut
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA
Surg Oncol Clin N Am 13:639-61, ix. 2004..Future clinical trials for resectable pancreatic cancer will lead to progress only if the principles of multidisciplinary cancer care and quality assurance are incorporated into their design and conduct...
Role of preoperative ultrasonography in the surgical management of patients with thyroid cancerMaria A Kouvaraki
Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Surgery 134:946-54; discussion 954-5. 2003..Ultrasound findings altered the operative procedure in these patients, facilitating complete resection of disease and potentially minimizing local-regional recurrence...
Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse modelRosa F Hwang
Department of Cancer Biology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Clin Cancer Res 9:6534-44. 2003....
Single-nucleotide polymorphisms of DNA damage response genes are associated with overall survival in patients with pancreatic cancerTaro Okazaki
Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Clin Cancer Res 14:2042-8. 2008....
Posterior retroperitoneoscopic adrenalectomy is a safe and effective alternative to transabdominal laparoscopic adrenalectomy for pheochromocytomaPaxton V Dickson
Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Surgery 150:452-8. 2011..Posterior retroperitoneoscopic adrenalectomy (PRA) is an alternative minimally invasive technique; however, there is a lack of data regarding the appropriateness of this approach in patients with PHEO...
Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancerRosa F Hwang
Department of Surgical Oncology, Unit 444, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
Ann Surg Oncol 15:1356-66. 2008..We describe the development of an integrated pancreatic tissue bank (PTB) and clinical database for patients with pancreatic cancer and other pancreatic disorders...
Postoperative radiotherapy for advanced medullary thyroid cancer--local disease control in the modern eraDavid L Schwartz
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
Head Neck 30:883-8. 2008..The purpose of this study is to catalog modern-era postoperative radiotherapy (external beam radiotherapy [EBRT]) outcomes for advanced medullary thyroid cancer...
Selected polymorphisms of DNA repair genes and risk of pancreatic cancerLi Jiao
Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Cancer Detect Prev 30:284-91. 2006....
Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy?Thomas A Aloia
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230 1402, USA
J Am Coll Surg 204:347-55. 2007..This study reexamined the frequency of delayed recovery and assessed other factors associated with adjuvant therapy administration after PD at a high-volume center...
One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United StatesJames C Yao
Department of Gastrointestinal Medical Oncology, Unit 426, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
J Clin Oncol 26:3063-72. 2008..Clinicians need to be become familiar with the natural history and patterns of disease progression, which are characteristic of these tumors...
Efficacy of 4D-CT preoperative localization in 2 patients with MEN 2AMaria Philip
Department of Endocrine Surgery and Surgical Ontology, M D Anderson Cancer Center, University of Texas Medical School, Houston, TX 77230, USA
J Surg Educ 65:182-5. 2008..We recommend the use of 4D-CT scanning because of its capacity to identify hyperfunctional parathyroid glands and to provide anatomic information important in preoperative planning...
Mechanisms of proinflammatory cytokine-induced biphasic NF-kappaB activationChristian Schmidt
Department of Molecular and Cellular Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Mol Cell 12:1287-300. 2003..These findings provide further insight into the regulation of cytokine-induced specific and temporal gene expression...
Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell deathTadashi Uwagawa
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 109:2142-53. 2007....
Elevated expression of vascular endothelial growth factor correlates with increased angiogenesis and decreased progression-free survival among patients with low-grade neuroendocrine tumorsJun Zhang
Department of Gastrointestinal Medical Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 109:1478-86. 2007..Vascular endothelial growth factor (VEGF) is a critical proangiogenic factor in solid tumors. However, its expression and role in human neuroendocrine tumor development and progression remains unclear...
RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumorsMaria A Kouvaraki
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77230-1402, USA
Thyroid 15:531-44. 2005..Recommendations on the timing of prophylactic thyroidectomy and the extent of surgery are based upon a model that utilizes genotype- phenotype correlations to stratify mutations into three risk levels...
Do the recent American Thyroid Association (ATA) Guidelines accurately guide the timing of prophylactic thyroidectomy in MEN2A?Elizabeth G Grubbs
Department of Surgical Oncology, University of Texas, M D Anderson Cancer Center, Houston, TX 77030, USA
Surgery 148:1302-9; discussion 1309-10. 2010..The aim of this study was to assess whether the clinical guidelines outlined in the ATA recommendations added to the specific mutation risk level could predict the presence of MTC on final pathology...
Surgical treatment of non-functioning pancreatic islet cell tumorsMaria A Kouvaraki
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
J Surg Oncol 89:170-85. 2005..Treatment of metastatic disease includes biologic agents, cytotoxic chemotherapy, and liver-directed therapies...
Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinomaXianzhou Song
Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
Cancer 117:734-43. 2011..Although previous studies have identified the role of Axl in the transformation, proliferation, survival, and invasion in cancers, the expression and functions of Axl in pancreatic cancer have not been studied in detail...
Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomographySteven E Rodgers
Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA
Surgery 140:932-40; discussion 940-1. 2006..This allows improved preoperative planning, particularly for the case of reoperation. In addition to the data that are provided, we present a novel classification scheme for use in parathyroid localization...
The argument for pre-operative chemoradiation for localized, radiographically resectable pancreatic cancerChristopher H Crane
Department of Radiation Oncology, Unit 97, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
Best Pract Res Clin Gastroenterol 20:365-82. 2006..Herein, we discuss the rationale for the use of pre-operative chemoradiation in pancreatic cancer, the results of treatment, and future strategies to address the pattern of disease recurrence...
High levels of nucleolar expression of nucleolin are associated with better prognosis in patients with stage II pancreatic ductal adenocarcinomaLan Peng
Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Clin Cancer Res 16:3734-42. 2010..However, the expression and significance of nucleolin in pancreatic ductal adenocarcinoma (PDA) have not been studied...
Localized adenocarcinoma of the pancreas: the rationale for preoperative chemoradiationJeffrey D Wayne
The Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
Oncologist 7:34-45. 2002..This paper examines the factors pertinent to clinical trial design for resectable pancreatic cancer, and carefully reviews the existing data supporting adjuvant and neoadjuvant therapy for potentially resectable disease...
The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer riskLi Jiao
Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Unit 426, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Cancer Lett 245:61-8. 2007..24-0.88) (P for interaction=0.03). The (312)Asp-(751)Gln was identified as the putative at risk haplotype. Our study shows that the XPD gene polymorphism could be a genetic risk modifier for smoking-related pancreatic cancer...
Tumor-node-metastasis staging of pancreatic adenocarcinomaMatthew H G Katz
Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
CA Cancer J Clin 58:111-25. 2008....
Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomasMaria A Kouvaraki
Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
J Clin Oncol 22:4762-71. 2004..The volume of metastases in the liver is the most important predictor of outcome...
Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cellsBailu Peng
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Clin Cancer Res 8:3628-38. 2002..We seek to determine the role of Smad4/DPC4 in the suppression of tumor cell growth and in the regulation of TGF-beta-mediated expression of cell-cycle regulatory genes p15(ink4b) and p21(waf1)...
Overexpression of synuclein-gamma in pancreatic adenocarcinomaZhongkui Li
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, PO Box 424, Houston, TX 77030, USA
Cancer 101:58-65. 2004..To identify the gene expression profile of pancreatic carcinoma, an important step in the process of developing new diagnostic and therapeutic strategies, the authors investigated the alteration of gene expression in this disease...
Clinical significance of distinguishing between follicular lesion and follicular neoplasm in thyroid fine-needle aspiration biopsyMichelle D Williams
Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
Ann Surg Oncol 16:3146-53. 2009..The purpose of this study was to evaluate a single institution's experience with indeterminate thyroid FNA results to determine if subclassification (neoplasm versus lesion) aids in identifying patients at higher risk for malignancy...
The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosisQiang G Dong
Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, TX 77030, USA
Oncogene 21:6510-9. 2002....
Restoring apoptosis in pancreatic cancer cells by targeting the nuclear factor-kappaB signaling pathway with the anti-epidermal growth factor antibody IMC-C225Guido M Sclabas
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
J Gastrointest Surg 7:37-43; discussion 43. 2003..Therefore, targeting the NF-kappaB signaling pathway with an anti-EGFR antibody may be one strategy to restore apoptosis in human pancreatic cancer cells, thereby enhancing the effect of chemotherapy and radiation therapy...
Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patientsTina W F Yen
Department of Surgical Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Surgery 134:890-9; discussion 899-901. 2003..Radiographic evidence of recurrent disease is unlikely when the calcitonin level is < or =250 pg/mL. These data could be used to develop a logical, cost-effective treatment and follow-up strategy for patients with MTC...
Significant associations of mismatch repair gene polymorphisms with clinical outcome of pancreatic cancerXiaoqun Dong
Department of Gastrointestinal Medical Oncology, Surgical Oncology, Pathology, and Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 4009, USA
J Clin Oncol 27:1592-9. 2009..DNA mismatch repair (MMR) is critical in maintaining genomic stability and may modulate the cellular response to gemcitabine. We hypothesized that genetic variations in MMR may affect the clinical outcome of patients with pancreatic cancer...
Preventable reoperations for persistent and recurrent papillary thyroid carcinomaMaria A Kouvaraki
Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX 77230, USA
Surgery 136:1183-91. 2004..Accurate preoperative staging and adherence to the suggested National Comprehensive Cancer Network treatment guidelines may minimize the need for cervical reoperation...
Expression and regulation of the novel vascular endothelial growth factor receptor neuropilin-1 by epidermal growth factor in human pancreatic carcinomaAlexander A Parikh
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 98:720-9. 2003..NRP-1 may act as a coreceptor for VEGF in pancreatic carcinoma, as it does in other tumor systems, thereby enhancing angiogenesis and the effect of VEGF on the growth of pancreatic adenocarcinoma...
Parathyroid carcinoma: a 22-year experienceNaifa L Busaidy
joint Baylor College of Medicine/The University of Texas M. D. Anderson Cancer Center Training Program in Endocrinology, Diabetes, and Metabolism, Houston, Texas, USA
Head Neck 26:716-26. 2004..A comprehensive multidisciplinary approach with surgery, radiation therapy, and medical treatment for hypercalcemia is needed to optimize patient outcome...
Improvement of sleep disturbance and neurocognitive function after parathyroidectomy in patients with primary hyperparathyroidismElizabeth A Mittendorf
Department of Surgical Oncology, University of Texas, M D Anderson Cancer Center, Houston, Texas 77030, USA
Endocr Pract 13:338-44. 2007..To investigate the frequency of the nontraditional symptoms of sleep disturbance and impaired cognitive functioning in patients with primary hyper-parathyroidism (PHPT) and to assess changes in such patients after parathyroidectomy...
Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatmentDavid L Schwartz
Department of Radiation Oncology, UT MD Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 74:1083-91. 2009..To review institutional outcomes for patients treated for differentiated thyroid cancer with postoperative conformal external beam radiotherapy (EBRT)...
Genotype-phenotype analysis in multiple endocrine neoplasia type 1Maria A Kouvaraki
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
Arch Surg 137:641-7. 2002..Such information may assist in the genetic counseling and surveillance of at-risk patients. A specific genotype-phenotype correlation is unlikely because of the heterogeneity of the mutations in the MEN1 gene...
Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcomePeter W T Pisters
Pancreatic Tumor Study Group, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
J Clin Oncol 20:2537-44. 2002....
Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiationSunil Krishnan
Department of Radiation Oncology, The University of Texas, M D Anderson Cancer Center, Houston, Texas, USA
Cancer 107:2589-96. 2006..Prognostic factors are inadequately defined for disease-free survival and overall survival in patients with LAPC who are receiving chemoradiation, so more definitive prognostic factors would be very useful for designing clinical trials...
Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?Christopher H Crane
Pancreatic Tumor Study Group, Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 52:1293-302. 2002..To retrospectively compare the toxicity and efficacy of concurrent gemcitabine-based chemoradiation with that of concurrent 5-fluorouracil (5-FU)-based chemoradiation in patients with unresectable pancreatic cancer...
Glutathione S-transferase gene polymorphisms and risk and survival of pancreatic cancerLi Jiao
Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 109:840-8. 2007..The authors hypothesized that genetic variants of glutathione S-transferase (GST) affect detoxification of carcinogens and anticancer agents in the human pancreas and, thus, the risk and survival of pancreatic cancer...
Dietary mutagen exposure and risk of pancreatic cancerDonghui Li
Department of Gastrointestinal Medical Oncology, Unit 426, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Cancer Epidemiol Biomarkers Prev 16:655-61. 2007..09 and 0.099, respectively. These data support the hypothesis that dietary mutagen exposure alone and in interaction with other factors contribute to the development of pancreatic cancer...
Adjuvant therapy for adenocarcinoma of the pancreas: analysis of reported trials and recommendations for future progressRobert A Wolff
Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Unit 426, Houston, TX, 77030, USA
Ann Surg Oncol 15:2773-86. 2008..A critical analysis of completed adjuvant trials will be provided and a framework for the conduct of future trials of adjuvant therapy proposed...
Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancerDonghui Li
Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Clin Cancer Res 9:991-7. 2003..The purpose of this study was to investigate the expression and copy number alteration of STK15 in pancreatic cancer...
Cisplatin, fluorouracil, interferon-alpha, and radiation as adjuvant therapy for resected pancreatic cancer: is there a future for this regimen and/or should we change our approach to research and treatment of patients with pancreatic cancer?Peter W T Pisters
Ann Surg 248:152-3. 2008
5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancerDonghui Li
Department of Gastrointestinal Medical Oncology, Unit 426, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA
Cancer Epidemiol Biomarkers Prev 14:1470-6. 2005..23 (0.88-20.3) for heavy drinkers with the TT genotype compared with nondrinkers with the CC/CT genotypes. These observations support a role for folate metabolism in pancreatic cancer, especially among smokers and heavy drinkers...
Radiation dose considerations in the palliative treatment of locally advanced adenocarcinoma of the pancreasAdrian A Wong
The University of Texas Medical School at San Antonio, San Antonio, Texas, USA
Am J Clin Oncol 28:227-33. 2005....
Administration of optimal biological dose and schedule of interferon alpha combined with gemcitabine induces apoptosis in tumor-associated endothelial cells and reduces growth of human pancreatic carcinoma implanted orthotopically in nude miceCarmen C Solorzano
Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA
Clin Cancer Res 9:1858-67. 2003....
Combined-modality treatment for operable pancreatic adenocarcinomaPeter W T Pisters
The University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
Oncology (Williston Park) 19:393-404, 409; discussion 409-10, 412-6. 2005..Many newer chemotherapeutic agents with efficacy in gastrointestinal cancers have yet to be investigated in the adjuvant and neoadjuvant settings...
The role of intraoperative radiotherapy in pancreatic cancerChristopher H Crane
Gastrointestinal Section, Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Box 97, Houston, TX 77030, USA
Surg Oncol Clin N Am 12:965-77. 2003....
ESPAC-1 trial of adjuvant therapy for resectable adenocarcinoma of the pancreasDouglas B Evans
Ann Surg 236:694; author reply 694-6. 2002
Failure to recognize multiple endocrine neoplasia 2B: more common than we think?Curtis J Wray
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Ann Surg Oncol 15:293-301. 2008..However, the diagnosis of MEN2B is often delayed beyond childhood, at which time medullary thyroid carcinoma (MTC) may be regionally advanced or metastatic. We examined the extent of this delay and its impact on the treatment of MTC...
Population-based study of islet cell carcinomaJames C Yao
Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA
Ann Surg Oncol 14:3492-500. 2007..We examine the epidemiology, natural history, and prognostic factors that affect the duration of survival for islet cell carcinoma by using population-based registries...
Patterns of self-reported symptoms in pancreatic cancer patients receiving chemoradiationCielito C Reyes-Gibby
Department of Epidemiology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
J Pain Symptom Manage 34:244-52. 2007..This study demonstrates the feasibility and usefulness of symptom assessment in chemoradiation protocols. Future studies with larger cohorts are needed to further characterize multiple symptoms associated with chemoradiation...
